Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 1906-1913, 2006. First published August 3, 2006; 10.1373/clinchem.2006.070508
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.070508v1
52/10/1906    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finehout, E. J.
Right arrow Articles by Lee, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finehout, E. J.
Right arrow Articles by Lee, K. H.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2006;52:1906-1913.)
© 2006 American Association for Clinical Chemistry, Inc.

Proteomics and Protein Markers

Proteomic Analysis of Cerebrospinal Fluid Changes Related to Postmortem Interval

Erin J. Finehout1, Zsofia Franck1, Norman Relkin2 and Kelvin H. Lee1,a

1 School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY; 2 Department of Neurology and Neuroscience, Cornell University Medical College, New York, NY.

aAddress correspondence to this author at: 120 Olin Hall, Ithaca, NY 14853. Fax 607-255-9166; e-mail: KHL9{at}cornell.edu.

Background: The study of proteins with altered production in postmortem cerebrospinal fluid (CSF) compared with antemortem CSF may improve the understanding of biochemical changes that occur immediately after death.

Methods: Two CSF samples (1 antemortem and 1 postmortem) were collected from 7 patients and analyzed by 2-dimensional gel electrophoresis. An analysis was also performed to identify proteins that showed a correlation between concentration change and postmortem interval. Tandem mass spectrometry was used to identify the proteins.

Results: Fifty-four protein spots were identified that showed a consistent and significant change in concentration in the postmortem CSF of all 7 patients (>3.5-fold, P <0.01). The proteins in these spots derive from a variety of functional groups, including cytoskeletal proteins, enzymes involved in glycolysis, and proteins that prevent oxidative stress. Fourteen protein spots were found to have an increase in production that correlated with postmortem interval.

Conclusions: Changes in protein production of postmortem vs antemortem CSF were studied. The proteins observed to change production in the postmortem CSF include several proteins previously observed as potential stroke biomarkers.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
J.-M. Lee, K. Blennow, N. Andreasen, O. Laterza, V. Modur, J. Olander, F. Gao, M. Ohlendorf, and J. H. Ladenson
The Brain Injury Biomarker VLP-1 Is Increased in the Cerebrospinal Fluid of Alzheimer Disease Patients
Clin. Chem., October 1, 2008; 54(10): 1617 - 1623.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.